Parkin and α-synuclein:: Opponent actions in the pathogenesis of Parkinson's disease

被引:7
|
作者
Baptista, MJ [1 ]
Cookson, MR [1 ]
Miller, DW [1 ]
机构
[1] NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA
来源
NEUROSCIENTIST | 2004年 / 10卷 / 01期
关键词
Lewy bodies; mitochondria; parkin; proteasome; synapses; synuclein;
D O I
10.1177/1073858403260392
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Dominant mutations in the gene for alpha-synuclein, a small presynaptic protein, can cause Parkinson's disease. Although there is still substantial debate about the precise mechanisms, alpha-synuclein is toxic to vulnerable neurons, probably as a result of its tendency to aggregate. Opposing this is another gene product that, when mutated, causes a recessive form of parkinsonism, parkin. Parkin has been recently shown to protect cells against alpha-synuclein toxicity. However, the precise details of the mechanism are unclear. This review will discuss the concept that there are multiple neuronal functions that are targeted by mutant alpha-synuclein, and in many cases, there is evidence that parkin can protect cells against damage to the same systems. The authors will also discuss ways in which to test some of these ideas, by using newly identified genes such as DJ-1 that cause similar phenotypes.
引用
收藏
页码:63 / 72
页数:10
相关论文
共 50 条
  • [31] NO parkin in Parkinson's disease
    Lancaster, JR
    SCIENCE, 2004, 304 (5679) : 1905 - 1905
  • [32] Parkin is a potential modifier of the phenotype of α-synuclein-associated familial Parkinson's disease
    Markopoulou, K
    Dickson, DW
    McComb, RD
    Avery, L
    Chase, BA
    MOVEMENT DISORDERS, 2004, 19 : S217 - S218
  • [33] Interaction between Parkin and α-Synuclein in PARK2-Mediated Parkinson's Disease
    Madsen, Daniel Aghaie
    Schmidt, Sissel Ida
    Blaabjerg, Morten
    Meyer, Morten
    CELLS, 2021, 10 (02) : 1 - 30
  • [34] Parkin and Parkinson's disease
    Mizuno, Y
    Hattori, N
    Mori, H
    Suzuki, T
    Tanaka, K
    CURRENT OPINION IN NEUROLOGY, 2001, 14 (04) : 477 - 482
  • [35] Role of parkin in defective ubiquitination and alpha-synuclein turnover in Parkinson's disease
    Dawson, TM
    NEUROBIOLOGY OF AGING, 2004, 25 : S70 - S70
  • [36] Synuclein-linked neuroimmunity and the pathogenesis of Parkinson's disease.
    Gendelman, Howard E.
    NEUROTOXICOLOGY, 2006, 27 (06) : 1162 - 1162
  • [37] α-Synuclein and Noradrenergic Modulation of Immune Cells in Parkinson's Disease Pathogenesis
    Butkovich, Laura M.
    Houser, Madelyn C.
    Tansey, Malu G.
    FRONTIERS IN NEUROSCIENCE, 2018, 12
  • [38] The role of the endolysosomal pathway in a-synuclein pathogenesis in Parkinson's disease
    Smith, Jessica K.
    Mellick, George D.
    Sykes, Alex M.
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2023, 16
  • [39] Calpain in the cleavage of alpha-synuclein and the pathogenesis of Parkinson's disease
    Shams, Ramsha
    Banik, Naren L.
    Haque, Azizul
    MOLECULAR BASIS OF NEUROPSYCHIATRIC DISORDERS: FROM BENCH TO BEDSIDE, 2019, 167 : 107 - 124
  • [40] Editorial: Biomarkers and Pathogenesis of Alpha-Synuclein in Parkinson's Disease
    Li, Puyu
    Xu, Pingyi
    Liu, Jun
    FRONTIERS IN AGING NEUROSCIENCE, 2021, 13